查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601276

研究抗體和試劑市場：按產品、技術、適應症、應用和最終用戶 - 2025-2030 年全球預測

Research Antibodies & Reagents Market by Product (Antibodies, Reagent), Technology (Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence), Indication, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，研究用抗體和試劑市值為165.4億美元，預計到2024年將達到185.5億美元，複合年成長率為12.02%，到2030年將達到366.2億美元。

研究抗體和試劑包括多種用於在免疫組織化學、流式細胞技術和西方印漬術等應用中檢測蛋白質和其他分子的產品。這些工具對於生物醫學研究、診斷和藥物開發至關重要。對抗體和試劑的需求源於它們在識別疾病生物標記、制定治療策略和確保準確的實驗結果方面的關鍵作用。這些產品最終用於學術研究機構、生物技術公司、製藥公司、臨床實驗室和委託研究組織。最近的市場成長是由慢性病的增加、蛋白質組學和基因組學的進步以及生物技術公司研發投資的增加所推動的。個人化醫療領域是一個特殊的機會，該領域對客製化診斷和治療解決方案的需求正在迅速成長。公司可以利用這一點，開發更具特異性且在檢測中產生更少背景噪音的創新試劑。然而，市場擴張面臨挑戰，包括生產抗體的高成本、嚴格的監管要求以及需要高技能人員執行和解釋複雜的實驗。此外，批次間差異和抗體交叉反應等問題也構成了主要障礙。為了推動業務成長，公司應專注於開發具有更高特異性和可重複性的重組和單株抗體。不斷發展的數位病理學領域也有潛力，其中試劑和先進成像技術的整合有望簡化工作流程並提高診斷準確性。市場競爭激烈，許多老牌和新興企業不斷創新以贏得市場佔有率。優先提供高品質、經濟高效和多功能解決方案的公司將在這個不斷變化的環境中取得成功。

主要市場統計
基準年[2023] 165.4億美元
預測年份 [2024] 185.5億美元
預測年份 [2030] 366.2億美元
複合年成長率（%） 12.02%

市場動態：快速發展的研究抗體和試劑市場的關鍵市場洞察

研究抗體和試劑市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 製藥和生物製藥公司的研究活動增加
    • 蛋白質體學和基因組學研究日益普及
    • 個人化醫療和蛋白質治療中研究性抗體和試劑的新趨勢
  • 市場限制因素
    • 抗體開發過程成本高
  • 市場機會
    • 加大研究抗體和試劑的研發力道
    • 越來越關注尋找新的生物標記
  • 市場挑戰
    • 對研究抗體和試劑品質以及結果缺乏可重複性的擔憂

波特五力戰略工具駕馭研究性抗體與試劑市場

波特的五力框架是了解研究抗體和試劑市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解研究抗體和試劑市場的外部影響

外部宏觀環境因素在塑造研究抗體和試劑市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解研究抗體/試劑市場的競爭狀況

研究抗體和試劑市場的詳細市場佔有率分析提供了對供應商績效的全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV定位矩陣研究抗體和試劑市場供應商的績效評估

FPNV定位矩陣是評估研究抗體和試劑市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 製藥和生物製藥公司的研究活動增加
      • 蛋白質體學和基因組學研究日益普及
      • 個人化醫療和蛋白質治療中研究性抗體和試劑的新趨勢
    • 抑制因素
      • 抗體開發過程高成本
    • 機會
      • 加強研究用抗體和試劑的研發
      • 人們越來越關注新生物標記的發現
    • 任務
      • 對研究抗體/試劑品質和缺乏可重複結果的擔憂
  • 市場區隔分析
    • 產品：抗體在目標蛋白的檢測和定量中變得越來越流行
    • 技術：在流式細胞技術中更多地使用研究抗體和試劑進行免疫表現型分析
    • 適應症：擴大在研抗體和試劑在感染疾病病原體鑑定上的應用
    • 應用：擴大使用研究性抗體和試劑來開發針對特定治療標靶的藥物
    • 最終用戶：擴大在製藥和生物技術公司中研究抗體和試劑的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 研究抗體與試劑市場：依產品

  • 抗體
    • 單株抗體
    • 多株抗體
    • 重組抗體
  • 試劑
    • 緩衝
    • 酵素
    • 穩定劑
    • 媒體與血清
    • 探測
    • 溶劑
    • 染料

第7章 研究抗體與試劑市場：依技術分類

  • 酵素免疫分析法
  • 流式細胞技術
  • 螢光
  • 免疫組織化學
  • 免疫沉澱分析法
  • 蛋白質印跡法

第8章 研究用抗體和試劑市場（按適應症）

  • 免疫學
  • 感染疾病
  • 神經生物學
  • 腫瘤學
  • 幹細胞

第9章研究抗體與試劑市場：依應用分類

  • 藥物開發
  • 基因組學
  • 蛋白質體學

第 10 章 研究抗體與試劑市場：依最終用戶

  • 學術/研究機構
  • 合約調查機構
  • 製藥/生物技術

第11章美洲抗體和試劑市場研究

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太研究抗體與試劑市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章：歐洲、中東和非洲研究抗體和試劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 金斯瑞擴大試劑服務範圍，包括環狀RNA和脂質奈米顆粒製劑
    • Bio-Rad Laboratories 擴大了與 Starbrite 染料結合的抗體標記物的陣容
    • 丹納赫收購 Abcam
    • ERS Genomics 與 Santa Cruz Biotechnology 簽署 CRISPR/Cas9 授權協議
    • Teknova 宣布開設新的 GMP 認證工廠，以提高自訂高品質生命科學試劑的生產能力
    • Lonza 集團收購 Synafix 以加強抗體藥物複合體產品
    • BD 和 A*STAR 合作推進流式細胞技術中的超高維分析用於免疫學研究
    • Teknova 和 Sartorius 旨在解決 AAV 生物加工中的關鍵痛點
    • Biotechne 和 Cell Signaling Technology 宣布合作檢驗簡單的西方抗體
    • Cytek Biosciences, Inc. 與 Bio-Rad Laboratories, Inc. 合作擴大試劑產品組合

公司名單

  • Dovetail Genomics LLC
  • Tosoh Corporation
  • Randox Laboratories Ltd.
  • Enzo Life Sciences, Inc.
  • GenScript Biotech Corporation
  • BASF SE
  • Bio-Rad Laboratories, Inc.
  • Alpha Teknova, Inc.
  • Cardinal Health, Inc.
  • Becton, Dickinson and Company
  • ImmunoPrecise Antibodies Ltd.
  • Charles River Laboratories International, Inc.
  • LifeSpan BioSciences, Inc.
  • Cell Signaling Technology, Inc.
  • Abbott Laboratories
  • bioMerieux SA
  • Atlas Antibodies AB
  • FUJIFILM Holdings Corporation
  • Santa Cruz Biotechnology, Inc.
  • QIAGEN NV
  • Tokyo Chemical Industry Co., Ltd.
  • Thermo Fisher Scientific, Inc.
  • Lonza Group Ltd.
  • Sino Biological, Inc.
  • PerkinElmer, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Rockland Immunochemicals, Inc.
  • Avantor, Inc.
  • Danaher Corporation
  • Leinco Technologies, Inc.
  • Agilent Technologies Inc.
  • Bio-Techne Corporation
  • Honeywell International Inc.
  • Illumia, Inc.
  • Omega Bio-tek, Inc.
  • LobaChemie Pvt. Ltd.
Product Code: MRR-0D217D5AE090

The Research Antibodies & Reagents Market was valued at USD 16.54 billion in 2023, expected to reach USD 18.55 billion in 2024, and is projected to grow at a CAGR of 12.02%, to USD 36.62 billion by 2030.

The scope of research antibodies and reagents encompasses a diverse array of products used for detecting proteins and other molecules in applications such as immunohistochemistry, flow cytometry, and western blotting. These tools are indispensable in biomedical research, diagnostics, and drug development. The necessity of antibodies and reagents stems from their crucial role in identifying disease biomarkers, developing therapeutic strategies, and ensuring accurate experimental outcomes. These products find end-use in academic research institutions, biotech and pharmaceutical companies, clinical laboratories, and contract research organizations. Recent market growth is driven by the rising prevalence of chronic diseases, advancements in proteomics and genomics, and the increasing investment in R&D by biotech firms. A notable opportunity lies in the personalized medicine sector, where the demand for tailored diagnostic and therapeutic solutions is surging. Companies can capitalize on this by developing innovative reagents that provide greater specificity and lower background noise in assays. However, market expansion faces challenges such as the high cost of antibody production, stringent regulatory requirements, and the need for highly skilled personnel to conduct and interpret complex experiments. Furthermore, issues such as batch-to-batch variability and cross-reactivity of antibodies pose significant hurdles. To foster business growth, companies should focus on developing recombinant and monoclonal antibodies with enhanced specificity and reproducibility. There is also potential in the growing field of digital pathology, where integrating reagents with advanced imaging technologies can streamline workflow efficiencies and improve diagnostic accuracies. The nature of the market is highly competitive, characterized by the presence of numerous established and emerging players constantly innovating to capture market share. Companies that prioritize offering high-quality, cost-effective, and versatile solutions are better positioned to thrive in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 16.54 billion
Estimated Year [2024] USD 18.55 billion
Forecast Year [2030] USD 36.62 billion
CAGR (%) 12.02%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Research Antibodies & Reagents Market

The Research Antibodies & Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing research activities by pharmaceutical and biopharmaceutical companies
    • Rising popularity of proteomics and genomics research
    • Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
  • Market Restraints
    • High cost of antibody development processes
  • Market Opportunities
    • Increasing R&D in research antibodies & reagents
    • Rising focus on discovering novel biomarkers
  • Market Challenges
    • Quality concerns and a lack of reproducible results of research antibodies & reagents

Porter's Five Forces: A Strategic Tool for Navigating the Research Antibodies & Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Research Antibodies & Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Research Antibodies & Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Research Antibodies & Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Research Antibodies & Reagents Market

A detailed market share analysis in the Research Antibodies & Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Research Antibodies & Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Research Antibodies & Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Research Antibodies & Reagents Market, highlighting leading vendors and their innovative profiles. These include Dovetail Genomics LLC, Tosoh Corporation, Randox Laboratories Ltd., Enzo Life Sciences, Inc., GenScript Biotech Corporation, BASF SE, Bio-Rad Laboratories, Inc., Alpha Teknova, Inc., Cardinal Health, Inc., Becton, Dickinson and Company, ImmunoPrecise Antibodies Ltd., Charles River Laboratories International, Inc., LifeSpan BioSciences, Inc., Cell Signaling Technology, Inc., Abbott Laboratories, bioMerieux S.A., Atlas Antibodies AB, FUJIFILM Holdings Corporation, Santa Cruz Biotechnology, Inc., QIAGEN N.V., Tokyo Chemical Industry Co., Ltd., Thermo Fisher Scientific, Inc., Lonza Group Ltd., Sino Biological, Inc., PerkinElmer, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Rockland Immunochemicals, Inc., Avantor, Inc., Danaher Corporation, Leinco Technologies, Inc., Agilent Technologies Inc., Bio-Techne Corporation, Honeywell International Inc., Illumia, Inc., Omega Bio-tek, Inc., and LobaChemie Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Research Antibodies & Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antibodies and Reagent. The Antibodies is further studied across Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Antibodies. The Reagent is further studied across Buffers, Enzymes, Fixatives, Media & Sera, Probes, Solvents, and Stains & Dyes.
  • Based on Technology, market is studied across Enzyme-linked Immunosorbent Assay, Flow Cytometry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation, and Western Blotting.
  • Based on Indication, market is studied across Immunology, Infectious Diseases, Neurobiology, Oncology, and Stem Cells.
  • Based on Application, market is studied across Drug Development, Genomics, and Proteomics.
  • Based on End User, market is studied across Academic & Research Institutions, Contract Research Organizations, and Pharmaceutical & Biotechnology.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing research activities by pharmaceutical and biopharmaceutical companies
      • 5.1.1.2. Rising popularity of proteomics and genomics research
      • 5.1.1.3. Emerging trend of research antibodies & reagents in personalized medicine and protein therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of antibody development processes
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing R&D in research antibodies & reagents
      • 5.1.3.2. Rising focus on discovering novel biomarkers
    • 5.1.4. Challenges
      • 5.1.4.1. Quality concerns and a lack of reproducible results of research antibodies & reagents
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Increasing popularity of antibodies for detection and quantification of target proteins
    • 5.2.2. Technology: Increasing usage of research antibodies & reagents in flow cytometry for immunophenotyping
    • 5.2.3. Indication: Expanding application of research antibodies & reagents for identification of pathogens in infectious diseases
    • 5.2.4. Application: Rising utilization of research antibodies and reagents for drug development tailored to specific therapeutic targets
    • 5.2.5. End-user: Expanding usage of research antibodies & reagents across pharmaceutical & biotechnology companies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Research Antibodies & Reagents Market, by Product

  • 6.1. Introduction
  • 6.2. Antibodies
    • 6.2.1. Monoclonal Antibodies
    • 6.2.2. Polyclonal Antibodies
    • 6.2.3. Recombinant Antibodies
  • 6.3. Reagent
    • 6.3.1. Buffers
    • 6.3.2. Enzymes
    • 6.3.3. Fixatives
    • 6.3.4. Media & Sera
    • 6.3.5. Probes
    • 6.3.6. Solvents
    • 6.3.7. Stains & Dyes

7. Research Antibodies & Reagents Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme-linked Immunosorbent Assay
  • 7.3. Flow Cytometry
  • 7.4. Immunofluorescence
  • 7.5. Immunohistochemistry
  • 7.6. Immunoprecipitation
  • 7.7. Western Blotting

8. Research Antibodies & Reagents Market, by Indication

  • 8.1. Introduction
  • 8.2. Immunology
  • 8.3. Infectious Diseases
  • 8.4. Neurobiology
  • 8.5. Oncology
  • 8.6. Stem Cells

9. Research Antibodies & Reagents Market, by Application

  • 9.1. Introduction
  • 9.2. Drug Development
  • 9.3. Genomics
  • 9.4. Proteomics

10. Research Antibodies & Reagents Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutions
  • 10.3. Contract Research Organizations
  • 10.4. Pharmaceutical & Biotechnology

11. Americas Research Antibodies & Reagents Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Research Antibodies & Reagents Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Research Antibodies & Reagents Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. GenScript Expands Range of Reagent Services, Adding Circular RNA and Lipid Nanoparticles Formulation
    • 14.3.2. Bio-Rad Laboratories, Inc. Extends Range of Antibody Markers Conjugated to StarBright Dyes
    • 14.3.3. Danaher to Acquire Abcam plc
    • 14.3.4. ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement
    • 14.3.5. Teknova Announces Opening of New GMP-Certified Facility, Increasing Manufacturing Capacity for Custom, High-Quality Life Sciences Reagents
    • 14.3.6. Lonza Group Ltd. to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
    • 14.3.7. BD and A*STAR Collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research
    • 14.3.8. Teknova and Sartorius Look to Address Critical Pain Points in AAV Bioprocessing
    • 14.3.9. Bio-Techne And Cell Signaling Technology Announce Partnership To Validate Simple Western Antibodies
    • 14.3.10. Cytek Biosciences, Inc. Partners with Bio-Rad Laboratories, Inc. to Expand Reagent Portfolios

Companies Mentioned

  • 1. Dovetail Genomics LLC
  • 2. Tosoh Corporation
  • 3. Randox Laboratories Ltd.
  • 4. Enzo Life Sciences, Inc.
  • 5. GenScript Biotech Corporation
  • 6. BASF SE
  • 7. Bio-Rad Laboratories, Inc.
  • 8. Alpha Teknova, Inc.
  • 9. Cardinal Health, Inc.
  • 10. Becton, Dickinson and Company
  • 11. ImmunoPrecise Antibodies Ltd.
  • 12. Charles River Laboratories International, Inc.
  • 13. LifeSpan BioSciences, Inc.
  • 14. Cell Signaling Technology, Inc.
  • 15. Abbott Laboratories
  • 16. bioMerieux S.A.
  • 17. Atlas Antibodies AB
  • 18. FUJIFILM Holdings Corporation
  • 19. Santa Cruz Biotechnology, Inc.
  • 20. QIAGEN N.V.
  • 21. Tokyo Chemical Industry Co., Ltd.
  • 22. Thermo Fisher Scientific, Inc.
  • 23. Lonza Group Ltd.
  • 24. Sino Biological, Inc.
  • 25. PerkinElmer, Inc.
  • 26. F. Hoffmann-La Roche Ltd.
  • 27. Merck KGaA
  • 28. Rockland Immunochemicals, Inc.
  • 29. Avantor, Inc.
  • 30. Danaher Corporation
  • 31. Leinco Technologies, Inc.
  • 32. Agilent Technologies Inc.
  • 33. Bio-Techne Corporation
  • 34. Honeywell International Inc.
  • 35. Illumia, Inc.
  • 36. Omega Bio-tek, Inc.
  • 37. LobaChemie Pvt. Ltd.

LIST OF FIGURES

  • FIGURE 1. RESEARCH ANTIBODIES & REAGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. RESEARCH ANTIBODIES & REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. RESEARCH ANTIBODIES & REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RESEARCH ANTIBODIES & REAGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RESEARCH ANTIBODIES & REAGENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY POLYCLONAL ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY RECOMBINANT ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FIXATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY MEDIA & SERA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY SOLVENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STAINS & DYES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOPRECIPITATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY NEUROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 312. SWITZERLAND RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY REAGENT, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. TURKEY RESEARCH ANTIBODIES & REAGENTS MARKET SIZE, BY END USER, 2018-2030 (US